Related Experiment Video
Updated: Oct 1, 2025

Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery
Published on: July 31, 2014
Creatine Kinase Is Associated With Recurrent Stroke and Functional Outcomes of Ischemic Stroke or Transient Ischemic
Shiyu Li1,2, Anxin Wang1,2, Yijun Zhang1,2
1Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.
Insights
Elevated serum creatine kinase (CK) in patients with acute ischemic stroke or transient ischemic attack is linked to increased risks of stroke recurrence, death, and disability. These associations were significant at 3 months and 1 year, with sex influencing outcomes.
Area of Science:
- Neurology
- Cardiology
- Biochemistry
Background:
- Elevated serum creatine kinase (CK) is frequently observed in post-stroke patients.
- Understanding the prognostic value of CK in acute ischemic stroke is crucial for patient management.
Purpose of the Study:
- To investigate the association between serum CK levels and clinical outcomes in patients with acute ischemic stroke or transient ischemic attack.
- To determine if CK levels can predict stroke recurrence, death, and disability.
Main Methods:
- Analysis of 8910 patients from the Third China National Stroke Registry (CNSR-III).
- Measurement of baseline serum CK levels post-admission.
- Statistical analysis of associations between CK levels and outcomes (stroke recurrence, death, disability at 3 months and 1 year).
Main Results:
- Elevated CK levels were significantly associated with higher risks of recurrent stroke (HR 1.53), death (HR 1.68), and disability (OR 1.57) at 3 months, persisting at 1 year.
- These associations remained significant after adjusting for confounding factors.
- The impact of CK on death and disability was more pronounced in male patients compared to females (P<0.05 for interaction).
- Elevated CK-MB levels did not show a significant association with clinical outcomes.
Conclusions:
- Elevated serum CK is a significant predictor of recurrent stroke, mortality, and disability in patients with acute ischemic stroke or transient ischemic attack.
- Serum CK serves as a valuable prognostic marker for poor functional outcomes.
- Sex is a modifying factor in the relationship between elevated CK and adverse clinical outcomes.
Abstract:
Background Many patients after stroke are found to have elevated serum creatine kinase (CK). This study aimed to investigate the associations between serum CK levels and clinical outcomes in patients with acute ischemic stroke or transient ischemic attack. Methods and Results The study included 8910 patients with acute ischemic stroke or transient ischemic attack from the CNSR-III (Third China National Stroke Registry). Baseline serum CK levels after admission were measured. The associations between CK and clinical outcomes (stroke recurrence, death, and disability, defined as modified Rankin scale score 3-6 or 2-6) were analyzed. Patients with elevated CK levels had higher risks of recurrent stroke (hazard ratio [HR], 1.53; 95% CI, 1.21-1.93), death (HR, 1.68; 95% CI, 1.10-2.58), and disability (modified Rankin scale score, 3-6; odds ratio, 1.57; 95% CI, 1.29-1.90) at 3 months after adjusting confounding factors. Similar results were found at 1 year. The effects of CK on death and disability were more significant in male patients than female patients (P value for interaction <0.05). Elevated CK-MB levels were not associated with clinical outcomes in this study. Conclusions Elevated serum CK after ischemic stroke or transient ischemic attack is associated with higher risks of recurrent stroke, death, and disability at 3 months and 1 year. Serum CK may act as a useful predictor for recurrent stroke and poor functional outcomes in patients with acute ischemic stroke or transient ischemic attack. Sex modifies the relationship between elevated CK and disability or death.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury I: Introduction

